Cargando…
Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice()
The technological advancement of the pharmaceutical industry, resulting from the techniques of molecular biology and expansion of the knowledge of immunopathogenesis, has modified the therapeutic arsenal used in dermatology. Scientific research and regulatory standards cause drug costs to rise, thus...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007493/ https://www.ncbi.nlm.nih.gov/pubmed/33573869 http://dx.doi.org/10.1016/j.abd.2020.08.010 |
_version_ | 1783672501486747648 |
---|---|
author | de Oliveira, Renan Tironi Giglio Agostinho, Giovana Larissa Prado Leite Granja, Rubens Oyafuso, Luiza Keiko M. Criado, Paulo Ricardo |
author_facet | de Oliveira, Renan Tironi Giglio Agostinho, Giovana Larissa Prado Leite Granja, Rubens Oyafuso, Luiza Keiko M. Criado, Paulo Ricardo |
author_sort | de Oliveira, Renan Tironi Giglio |
collection | PubMed |
description | The technological advancement of the pharmaceutical industry, resulting from the techniques of molecular biology and expansion of the knowledge of immunopathogenesis, has modified the therapeutic arsenal used in dermatology. Scientific research and regulatory standards cause drug costs to rise, thus making their use impossible in most public policies. In order to make high-cost drugs viable in the public health network, the Specialized Pharmaceutical Assistance Component was created. However, despite the frequent incorporation of medications, the constant requirement of drugs through lawsuits leads to exorbitant costs to the state budget. The present work analyzed through a descriptive observational study, the current situation of the Specialized Component and the involvement of medicines used in dermatology, through legal reviews, financial analyses, and medical articles, aiming at future incorporations for the specialty. When assessing the legal demands for dermatological drugs in the state of São Paulo, the specialty still has a low participation and psoriasis is the main disease involved in requiring drugs through the judicial system in the state. New methods of access to raw materials must be created to reduce legal issues. Cost-effectiveness and public planning studies are mandatory for incorporating new dermatological therapies. |
format | Online Article Text |
id | pubmed-8007493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedade Brasileira de Dermatologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-80074932021-04-01 Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice() de Oliveira, Renan Tironi Giglio Agostinho, Giovana Larissa Prado Leite Granja, Rubens Oyafuso, Luiza Keiko M. Criado, Paulo Ricardo An Bras Dermatol Review The technological advancement of the pharmaceutical industry, resulting from the techniques of molecular biology and expansion of the knowledge of immunopathogenesis, has modified the therapeutic arsenal used in dermatology. Scientific research and regulatory standards cause drug costs to rise, thus making their use impossible in most public policies. In order to make high-cost drugs viable in the public health network, the Specialized Pharmaceutical Assistance Component was created. However, despite the frequent incorporation of medications, the constant requirement of drugs through lawsuits leads to exorbitant costs to the state budget. The present work analyzed through a descriptive observational study, the current situation of the Specialized Component and the involvement of medicines used in dermatology, through legal reviews, financial analyses, and medical articles, aiming at future incorporations for the specialty. When assessing the legal demands for dermatological drugs in the state of São Paulo, the specialty still has a low participation and psoriasis is the main disease involved in requiring drugs through the judicial system in the state. New methods of access to raw materials must be created to reduce legal issues. Cost-effectiveness and public planning studies are mandatory for incorporating new dermatological therapies. Sociedade Brasileira de Dermatologia 2021 2021-01-30 /pmc/articles/PMC8007493/ /pubmed/33573869 http://dx.doi.org/10.1016/j.abd.2020.08.010 Text en © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review de Oliveira, Renan Tironi Giglio Agostinho, Giovana Larissa Prado Leite Granja, Rubens Oyafuso, Luiza Keiko M. Criado, Paulo Ricardo Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice() |
title | Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice() |
title_full | Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice() |
title_fullStr | Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice() |
title_full_unstemmed | Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice() |
title_short | Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice() |
title_sort | socioeconomic impact of high-cost drugs in brazilian dermatology. legal and financial aspects, and impact on clinical practice() |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007493/ https://www.ncbi.nlm.nih.gov/pubmed/33573869 http://dx.doi.org/10.1016/j.abd.2020.08.010 |
work_keys_str_mv | AT deoliveirarenantironigiglio socioeconomicimpactofhighcostdrugsinbraziliandermatologylegalandfinancialaspectsandimpactonclinicalpractice AT agostinhogiovanalarissapradoleite socioeconomicimpactofhighcostdrugsinbraziliandermatologylegalandfinancialaspectsandimpactonclinicalpractice AT granjarubens socioeconomicimpactofhighcostdrugsinbraziliandermatologylegalandfinancialaspectsandimpactonclinicalpractice AT oyafusoluizakeikom socioeconomicimpactofhighcostdrugsinbraziliandermatologylegalandfinancialaspectsandimpactonclinicalpractice AT criadopauloricardo socioeconomicimpactofhighcostdrugsinbraziliandermatologylegalandfinancialaspectsandimpactonclinicalpractice |